openPR Logo
Press release

Real World Evidence Market, (2nd Edition) - Roots Analysis

11-10-2021 05:20 AM CET | Health & Medicine

Press release from: Roots Analysis

Real World Evidence Market, (2nd Edition) - Roots Analysis

In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA routinely uses real world evidence to monitor post market safety of drugs

Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings.

The digitization of data and advances in information processing, have led to the development of a wide array of tools and analytical algorithms that can now be used to mine pharmaceutical big data. The insights generated from such studies are increasingly being used to drive important judgements concerning pharmacology and healthcare. Presently, big pharmaceutical companies are estimated to spend nearly USD 20 million on an annual basis, on the generation of real world evidence to support their respective product development programs.

To order this 350+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/pharmaceutical-real-world-evidence-market/261.html

Key Market Insights

Over 240 companies claim to offer real world evidence-related services for various applications
More than 45% of these companies are start-ups / small sized players (with less than 50 employees). It is also worth highlighting that 27% of the stakeholders in this market claim to use patient powered data; the second most popular source of real world data that is used by 26% of service providers is clinical setting data.

More than 90% of the companies involved in this upcoming field of research, are based in the developed regions
Within North America, most of the real world evidence focused companies are headquartered in the US. Considering its technological superiority and the fact that it is generally open to accepting new paradigms, the US market is presently considered a hub for real world data research. In Europe, companies that claim to specialize in real world evidence are distributed across the UK, France, Ireland, and Switzerland.

Over 100 global events related to real world evidence were organized in the past couple of years
Among the active industry players, Pfizer participated in most of these events (70), followed by Merck, Janssen, Sanofi, Amgen, Eli Lilly, GSK and AstraZeneca. These events featured the participation of several non-industry players as well, which includes US FDA, University of California, Harvard Medical School and Stanford University.

Close to 2,200 articles on real world evidence have been published in reputed scientific journals since 2016
More than 20% of the publications mentioned in the report, were focused on generating / using real word evidence-based insights for the assessment of treatment safety / effectiveness of various medical products. Popular journals, in terms of number of real-world evidence-related articles published, include Pharmacoepidemiology and Drug Safety, The New England Journal of Medicine, Diabetes Therapy, and Diabetes, Obesity and Metabolism.

In the last 10 years, close to 1,600 clinical trials informed using real world evidence have been registered
The number of such trials, that have been registered in the recent past, have increased at a CAGR of 21% from 2010 to 2019. Majority of these trials are focused on cardiovascular disorders, oncological disorders and neurological disorders. Amidst the COVID-19 pandemic, several trials focused on the novel coronavirus related condition have been informed using real world data.

North America and Europe are anticipated to capture over 65% of the market share by 2030
Based on the analysis in the report, the North American real world evidence market is estimated to grow at the fastest pace (around 16% annualized growth), in terms of service revenues. Further, it is worth mentioning that the real world evidence services market in the Latin America is anticipated to grow annually at 15.5%, followed by Middle East and North Africa (12.7%).

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/228/request-sample.html

Key Questions Answered

 Who are the leading players offering real world evidence-related services?
 What is the current regulatory framework related to generation of real world data across various geographies?
 What are the key drivers of acquisition activity within the real world evidence market?
 Where in the world are clinical trial informed using real world evidence, being conducted?
 How has the COVID-19 pandemic impacted the real world evidence market?
 What is the cost saving potential associated with the use of real world evidence in drug discovery research?
 How is the current and future opportunity likely to be distributed across key market segments?

The USD 4.5 billion (by 2030) financial opportunity within the real world evidence market has been analyzed across the following segments:
 Type of Application
 Early Stage Research
 Clinical Development
 Regulatory Approval, Pricing / Reimbursement
 Post-Approval Studies

 Types of Real World Data Sources
 Medical Claims
 Clinical Trials
 Clinical Setting
 Patient Powered
 Other Data Sources

 Therapeutic Area
 Autoimmune Disorders
 Cardiovascular Disorders
 Infectious Diseases
 Metabolic Disorders
 Neurological / Psychiatric Disorders
 Oncological Disorders
 Respiratory Disorders
 Other Disorders

 Geography
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/pharmaceutical-real-world-evidence-market/261.html

The report features inputs from eminent industry stakeholders, according to whom the use of real world evidence has the potential to reduce drug approval timelines by about five years, and the associated capital investment in R&D, by 50-60%. The report includes detailed transcripts of the discussions held with the following industry experts:
 Limor BH Epstein (Founder, Data2Life)
 Fernando Santa (Chief Operating Officer, Adarna Health Data)
 Jonathan Moshinsky (Chief Strategy Officer, uMotif)
 Anonymous (Vice President, A Big Pharmaceutical Company)
 Wirth Peter (Vice President, RTI Health Solutions)
 Douglas Drake (Senior Director, Clinerion)
 Jane Reed (Director, Life Sciences, Linguamatics)
 Anonymous (Savana)

The research includes profiles of some of the key players (listed below) in this filed, each profile features an overview of the company, information related to its real world evidence-related technologies / platforms / services portfolio, recent developments and an informed future outlook.
 Clinerion
 Clinigen Group
 Cognizant Analytics
 Evidera
 HealthCore
 IBM Watson Health (IBM)
 ICON
 IQVIA
 Medpace
 NorthWest EHealth
 OptumInsight
 Oracle
 PAREXEL
 PerkinElmer
 SAS
 Syneos Health
 TriNetX

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/pharmaceutical-real-world-evidence-market/261.html

You may also be interested in the following titles:
1. Drug Repurposing Service Providers Market, 2020-2030
2. Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030
3. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030: Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive) and Purpose of Solution (Medication Replacement and Medication Augmentation)

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com

We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Real World Evidence Market, (2nd Edition) - Roots Analysis here

News-ID: 2456436 • Views:

More Releases from Roots Analysis

The Agricultural Biologicals Market Size Worth over USD 40 Billion in 2035 | Roo …
Global Agricultural Biologicals Market Overview The agricultural biologicals market is a rapidly growing and dynamic industry that is poised to grow at a CAGR of 9.98% in the forecast period 2023-2035. The growth in the agricultural biologicals market size over the next decade is likely to be the result of a rise in the demand for organic food coupled with the growing focus on sustainable agriculture. Agricultural biologics include a vast
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035, claims Roots Analysis
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035 …
Owing to the advanced features and cost-saving potential of automation, stakeholders in the healthcare industry are adopting lab automation systems in order to get precise results and reduce deviations occurring due to manual handling Roots Analysis has announced the addition of "Lab Automation Market, 2023-2035" report to its list of offerings. The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology
The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development London Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings. Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type
The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis
The companion diagnostics development services market, is anticipated to grow at …
Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings. The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of

All 5 Releases


More Releases for North

North America Epoxy Composites Market
North America Epoxy Composites Market, By Type (Glass Fiber, Cotton Fiber, Paper Fiber), Resin Type (Epoxy Resin, Phenolic Resin, Melamine Resin), Manufacturing Process (Layup Process, Compression Molding Process, Resin Injection Molding Process, Resin Transfer Molding Process, Filament Winding Process, Pultrusion Process), End User (Wind Energy, Aerospace and Defense, Sporting Goods, Automotive and Transportation, Electrical and Electronics, Pipe and Tank, Marine, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to
North America Drone Simulator industry report - North America Drone Simulator Ma …
The drone simulator market in North America is expected to reach US$ 535.17 million by 2028 from US$ 251.38 million in 2021; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. The latest North America Drone Simulator Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis
UberJets Helping People Get North!
In 2022 consumers have the freedom to purchase, order, or reserve, practically anything with a click of a button. Buying has never been more transparent through the utilization of mobile app technology. Typically, users can perform tasks such as book a hotel or purchase game tickets all from an app; so it only makes sense that one can order a private aircraft to get to anywhere, and anytime using the
02-07-2020 | Health & Medicine
CRIFAX
North America Apnea Monitors Market : North America Opportunity Analysis and Ind …
CRIFAX has recently announced its latest research report on 'North America Apnea Monitors Market, 2020-2028' to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key players to stay ahead of the game. Additionally, recent trends, mergers and acquisitions, region-wise growth analysis along with challenges that are affecting the growth of the market are also stated
North America Footwear Market -Consumers In North America Are More Inclined Towa …
In the last couple of years, North America has emerged at the forefront of the fashion and sports apparel industry. Not only has easy and uninterrupted internet access bolstered consumer awareness regarding the latest buzz in the fashion scenario, but it has also helped them shop for the products they want with a simple touch of their fingers on their smartphones or tablets. The developed countries in the region such
Electrical Fuses Market: Production Enterprise To Become Main Application Phase …
The North America electrical fuses market is likely to witness the advent of more compact and slimmer electronics with leading players vying to cater to ever-changing consumer preferences. The development of the latest technologies and innovation have thus emerged as the most defining trends in the market. The electrical fuses market in North America is primarily driven by the rising demand for electricity and efficient power delivery systems. Besides this,